In an economic evaluation of vaccination against rotavirus conducted in Italy, it was shown that as early as the second year after rotavirus vaccine introduction, the vaccine cost would be more than offset by savings from prevention of disease cases and hospitalizations.
Full Citation:
Carroll, S., García Rojas, A. J., et al.. 2015. Vaccination: short- to long-term benefits from investment. Market Access & Health Policy. 3(1).
Title of Article: Vaccination: short- to long-term benefits from investment
Author(s): Carroll, S., García Rojas, A. J., et al.
Publication Year: 2015
Publication Name: Market Access & Health Policy
Publication Volume: 3(1)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/27123171/
DOI (Digital Object Identifier): http://dx.doi.org/10.3402/jmahp.v3.27279
Topics: Economics & Return on Investment
Disease Vaccines: Diarrhea | Rotavirus
Countries: Italy
WHO Regions: Europe